Enteropathogen antibody dynamics and force of infection among children in low-resource settings

  1. Benjamin F Arnold  Is a corresponding author
  2. Diana L Martin
  3. Jane Juma
  4. Harran Mkocha
  5. John B Ochieng
  6. Gretchen M Cooley
  7. Richard Omore
  8. E Brook Goodhew
  9. Jamae F Morris
  10. Veronica Costantini
  11. Jan Vinjé
  12. Patrick J Lammie
  13. Jeffrey W Priest
  1. University of California, Berkeley, United States
  2. United States Centers for Disease Control and Prevention, United States
  3. Kenya Medical Research Institute, Kenya
  4. Kongwa Trachoma Project, United Republic of Tanzania
  5. Georgia State University, United States
  6. Task Force for Global Health, United States

Abstract

Little is known about enteropathogen seroepidemiology among children in low-resource settings. We measured serological IgG responses to eight enteropathogens (Giardia intestinalis, Cryptosporidium parvum, Entamoeba histolytica, Salmonella enterica, enterotoxigenic Escherichia coli, Vibrio cholerae, Campylobacter jejuni, norovirus) in cohorts from Haiti, Kenya, and Tanzania. We studied antibody dynamics and force of infection across pathogens and cohorts. Enteropathogens shared common seroepidemiologic features that enabled between-pathogen comparisons of transmission. Overall, exposure was intense: for most pathogens the window of primary infection was <3 years old; for highest transmission pathogens primary infection occurred within the first year. Longitudinal profiles demonstrated significant IgG boosting and waning above seropositivity cutoffs, underscoring the value of longitudinal designs to estimate force of infection. Seroprevalence and force of infection were rank-preserving across pathogens, illustrating the measures provide similar information about transmission heterogeneity. Our findings suggest antibody response can be used to measure population-level transmission of diverse enteropathogens in serologic surveillance.

Data availability

Analyses were conducted in R version 3.5.3. Data and computational notebooks used to complete the analyses are available through GitHub and the Open Science Framework (osf.io/r4av7).

The following data sets were generated

Article and author information

Author details

  1. Benjamin F Arnold

    Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, United States
    For correspondence
    benarnold@berkeley.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6105-7295
  2. Diana L Martin

    Division of Parasitic Diseases and Malaria, United States Centers for Disease Control and Prevention, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Jane Juma

    Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  4. Harran Mkocha

    Kongwa Trachoma Project, Kongwa, United Republic of Tanzania
    Competing interests
    The authors declare that no competing interests exist.
  5. John B Ochieng

    Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  6. Gretchen M Cooley

    Division of Parasitic Diseases and Malaria, United States Centers for Disease Control and Prevention, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Richard Omore

    Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  8. E Brook Goodhew

    Division of Parasitic Diseases and Malaria, United States Centers for Disease Control and Prevention, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Jamae F Morris

    Department of African-American Studies, Georgia State University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Veronica Costantini

    Division of Viral Diseases, United States Centers for Disease Control and Prevention, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Jan Vinjé

    Division of Viral Diseases, United States Centers for Disease Control and Prevention, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Patrick J Lammie

    Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Jeffrey W Priest

    Division of Foodborne, Waterborne, and Environmental Diseases, United States Centers for Disease Control and Prevention, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.

Funding

National Institutes of Health (K01-AI119180)

  • Benjamin F Arnold

Bill and Melinda Gates Foundation (OPP1022543)

  • Patrick J Lammie

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: In Haiti, the human subjects protocol was reviewed and approved by the Ethical Committee of St. Croix Hospital (Leogane, Haiti) and the institutional review board at the US Centers for Disease Control and Prevention (CDC). After listening to an overview of the study, individuals were asked for verbal consent to participate. Verbal consent was deemed appropriate by both review boards because of low literacy rates in the study population. With each longitudinal visit, the study team re-consented participants before specimen collection. Mothers provided consent for children under 7, and children 7 years and older provided additional verbal assent. In Kenya, the human subjects protocol was reviewed and approved by institutional review boards at the Kenya Medical Research Institute (KEMRI) and at the US CDC. Primary caretakers provided written informed consent for their infant child's participation in the trial and blood specimen collection and testing. The original trial was registered at clinicaltrials.org (NCT01695304). In Tanzania, the human subjects protocol was reviewed and approved by the Institute for Medical Research Ethical Review Committee in Dar es Salaam, Tanzania and the institutional review board at the US CDC. Parents of enrolled children provided consent, and children 7 years and older also provided verbal assent before specimen collection.

Reviewing Editor

  1. Mark Jit, London School of Hygiene & Tropical Medicine, and Public Health England, United Kingdom

Publication history

  1. Received: January 29, 2019
  2. Accepted: August 15, 2019
  3. Accepted Manuscript published: August 19, 2019 (version 1)
  4. Version of Record published: September 16, 2019 (version 2)

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 1,855
    Page views
  • 255
    Downloads
  • 9
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Benjamin F Arnold
  2. Diana L Martin
  3. Jane Juma
  4. Harran Mkocha
  5. John B Ochieng
  6. Gretchen M Cooley
  7. Richard Omore
  8. E Brook Goodhew
  9. Jamae F Morris
  10. Veronica Costantini
  11. Jan Vinjé
  12. Patrick J Lammie
  13. Jeffrey W Priest
(2019)
Enteropathogen antibody dynamics and force of infection among children in low-resource settings
eLife 8:e45594.
https://doi.org/10.7554/eLife.45594

Further reading

    1. Epidemiology and Global Health
    2. Evolutionary Biology
    Marta Matuszewska et al.
    Research Article

    Mobile genetic elements (MGEs) are agents of horizontal gene transfer in bacteria, but can also be vertically inherited by daughter cells. Establishing the dynamics that led to contemporary patterns of MGEs in bacterial genomes is central to predicting the emergence and evolution of novel and resistant pathogens. Methicillin-resistant Staphylococcus aureus (MRSA) clonal-complex (CC) 398 is the dominant MRSA in European livestock and a growing cause of human infections. Previous studies have identified three categories of MGEs whose presence or absence distinguishes livestock-associated CC398 from a closely related and less antibiotic-resistant human-associated population. Here, we fully characterise the evolutionary dynamics of these MGEs using a collection of 1180 CC398 genomes, sampled from livestock and humans, over 27 years. We find that the emergence of livestock-associated CC398 coincided with the acquisition of a Tn916 transposon carrying a tetracycline resistance gene, which has been stably inherited for 57 years. This was followed by the acquisition of a type V SCCmec that carries methicillin, tetracycline, and heavy metal resistance genes, which has been maintained for 35 years, with occasional truncations and replacements with type IV SCCmec. In contrast, a class of prophages that carry a human immune evasion gene cluster and that are largely absent from livestock-associated CC398 have been repeatedly gained and lost in both human- and livestock-associated CC398. These contrasting dynamics mean that when livestock-associated MRSA is transmitted to humans, adaptation to the human host outpaces loss of antibiotic resistance. In addition, the stable inheritance of resistance-associated MGEs suggests that the impact of ongoing reductions in antibiotic and zinc oxide use in European farms on livestock-associated MRSA will be slow to be realised.

    1. Epidemiology and Global Health
    Shaun Truelove et al.
    Research Article Updated

    In Spring 2021, the highly transmissible SARS-CoV-2 Delta variant began to cause increases in cases, hospitalizations, and deaths in parts of the United States. At the time, with slowed vaccination uptake, this novel variant was expected to increase the risk of pandemic resurgence in the US in summer and fall 2021. As part of the COVID-19 Scenario Modeling Hub, an ensemble of nine mechanistic models produced 6-month scenario projections for July–December 2021 for the United States. These projections estimated substantial resurgences of COVID-19 across the US resulting from the more transmissible Delta variant, projected to occur across most of the US, coinciding with school and business reopening. The scenarios revealed that reaching higher vaccine coverage in July–December 2021 reduced the size and duration of the projected resurgence substantially, with the expected impacts was largely concentrated in a subset of states with lower vaccination coverage. Despite accurate projection of COVID-19 surges occurring and timing, the magnitude was substantially underestimated 2021 by the models compared with the of the reported cases, hospitalizations, and deaths occurring during July–December, highlighting the continued challenges to predict the evolving COVID-19 pandemic. Vaccination uptake remains critical to limiting transmission and disease, particularly in states with lower vaccination coverage. Higher vaccination goals at the onset of the surge of the new variant were estimated to avert over 1.5 million cases and 21,000 deaths, although may have had even greater impacts, considering the underestimated resurgence magnitude from the model.